Clinical Trials
6
Active:5
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)INNO-105 in Patients With Solid Tumors
Phase 1
Terminated
- Conditions
- Tumors
- First Posted Date
- 2005-11-18
- Last Posted Date
- 2007-05-14
- Lead Sponsor
- Innovive Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT00255333
- Locations
- 🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Mary Crowley Medical Research Center, Dallas, Texas, United States
News
No news found